Mets Mailbag: Jerry Koosman Tribute, Bichette’s Future & The 74-Win Title

New York Mets · 2026-11-02 · Beatline Sports Podcast Network

Sarah: We just won the division with eighty-eight losses. That is not a typo. That is baseball history, and it is wilder than anything we could have scripted.

Tom: It really was a collapse by everyone else, but the Mets held their ground. And today, we are going deep into your mailbag to sort out what this roster actually looks like heading into free agency.

Sarah: Welcome back to the Beatline Podcast Network! I’m Sarah, and I’m joined by Tom. We are talking New York Mets. Today we cover three big things: Jerry Koosman’s legacy and passing, Bo Bichette’s new home in Queens, and whether that bullpen can survive another October.

Tom: Right. We have a stacked rotation of questions for you all. Let’s get into it.

Sarah: First up, we have to address the news that broke Sunday. Jerry Koosman, who got the final out of the Miracle Mets' shocking 1969 World Series victory over the Baltimore Orioles, died at eighty-three.

Tom: A true icon. He was an All-Star left-hander who defined an era for this franchise. His passing reminds us why that 1969 team still matters so much to the identity of this city.

Sarah: It does. It connects the past to this weird, wonderful 2026 season where we somehow finished first in the NL East despite the record. Now, let’s open the mailbag.

Sarah: Our first question comes from Marcus in Denver. He asks: 'With Bo Bichette exercising his forty-two million dollar player option to remain with the New York Mets next season, how do you justify keeping him at third base after his defensive struggles last year?'

Tom: Okay, Marcus. This is the tactical heart of the matter. Bichette exercised that option on Friday. The Mets are locking him in for forty-two million dollars. But moving him from shortstop to third is a massive shift.

Sarah: It is. In our previous episodes, we talked about Francisco Lindor holding down the shortstop role firmly. So Bichette has to make sense at the hot corner. Is it worth the risk?

Tom: It’s about offense outweighing defense. Bichette is a elite bat. If he can hold his own at third, which he did somewhat last year, you keep his bat in the lineup. You don’t bench a hitter of his caliber because of range issues.

Sarah: So you’re saying the offensive upside justifies the defensive liability? What about the infield chemistry? Brett Baty is also there.

Tom: Baty is versatile, but Bichette is the anchor here. The front office believes they can coach up the defense or mitigate it with positioning. It’s a calculated gamble on his bat.

Sarah: Fair point. Next question comes from @QueensFan88. She asks: 'You mentioned Kodai Senga in the bullpen last week. With Tarik Skubal being MLB’s top free agent, is the Mets’ plan to use Senga as a long-relief ace or a starter if Skubal signs elsewhere?'

Tom: @QueensFan88, great question. We predicted earlier that the Mets would utilize a four-man rotation with Senga in the bullpen. That remains the core strategy. Whether Skubal signs with the Dodgers or Yankees, as we also guessed, doesn't change Senga's role.

Sarah: Right, because Senga has shown he can dominate in relief. Devin Williams is already there. Do you see Senga and Williams forming a scary one-two punch in late innings?

Tom: Absolutely. Williams brings the strikeout stuff, Senga brings the movement and control. It’s a terrifying combination for opposing hitters. It allows Sean Manaea and Zac Thornton to pitch deeper into games without burning the arm.

Sarah: That is huge for stamina. One more from Sarah from Rochester: 'Did the Mets miss out on Tarik Skubal? He’s a two-time Cy Young Award winner. Why not go after him?'

Tom: They didn't miss out; they probably couldn't afford him. Skubal will command a historic contract. The Mets are managing their payroll carefully after the Bichette extension. They prefer internal solutions like Senga over spending wildly on external ones.

Sarah: Smart moneyball approach. Okay, listeners, before we dive into the roster battles, we need a quick moment. If today’s episode helped you understand this bizarre season better, please consider supporting the show. Your contributions keep this daily content free and allow us to dig into these details. Just click the link in the episode description to help us out. Thanks, guys.

Sarah: Welcome back. Let’s talk roster construction. Jonathan in Chicago asks: 'The outfield looks crowded. Juan Soto is in left, but who is playing center and right? How do you fit A.J. Ewing and Carson Benge?'

Tom: Jonathan, this is the depth chart puzzle. Juan Soto is locked in left field. He’s a superstar. The center field job is tricky. A.J. Ewing has speed, but defensively, it’s unproven at this level.

Sarah: And Carson Benge in right? Is he ready for everyday reps?

Tom: Benge is young. He might split time with Nick Morabito in left or right. The Mets have options, but none are superstars yet. It’s a gap between Soto and the rest of the group.

Sarah: So Soto carries the load offensively? What about the infield? Luis Torrens is catching. Does he start over Francisco Alvarez?

Tom: Torrens is the veteran presence. Alvarez is the power bat. I expect them to split time. Alvarez needs development, but his bat is too good to sit. The catcher spot isn't settled, which worries me slightly for consistency.

Sarah: Splitting time at catcher is common, but can Alvarez handle the pitching staff? Or will Hayden Senger see more action?

Tom: Senger is the backup. Alvarez gets the nod most days unless he’s slumping. The issue is the defensive framing. Alvarez needs to improve there to be a full-time starter.

Sarah: Let’s look at second base. Marcus Semien and Kyren Paris. Who wins the job?

Tom: Semien is the incumbent. He’s proven. Paris is the prospect. Unless Paris blows them away in camp, Semien starts. It’s about stability at a position that can be volatile.

Sarah: Stability is key when you’re trying to build on a division title. One last question for this segment from @MetsMagical: 'What about Eric Wagaman? You predicted he’d be traded or released. Is he still around?'

Tom: @MetsMagical, you know me well. Yes, Wagaman is still on the roster list. But my prediction stands. He will likely be moved before the 2027 season starts. There are better options at first base with Mark Vientos and Christopher Morel available.

Sarah: So Vientos and Morel are the competition? What about Jared Young?

Tom: Young is depth. Vientos and Morel are the real threats. The front office will likely cut one of them to make room for other needs. Wagaman is the expendable piece here.

Sarah: Alright, final segment. Fun hypothetical time. If you could draft one player from the Red Sox or Diamondbacks Gold Glove winners to join the Mets, who takes the call?

Tom: Matt Olson won his fourth Gold Glove. He’s a first baseman. Imagine Olson and Soto. The power numbers would be insane. But defensively? Maybe not the best fit. I’ll take Wilyer Abreu in right field. Boston’s right fielder won his third straight. He’s young, athletic, and fits perfectly next to Soto.

Sarah: Abreu sounds great. He’s only twenty-three. I love that energy. Lightning round! First name that comes to mind when you think of Mets defense?

Tom: Lindor. No contest. He anchors everything.

Sarah: Best bullpen move of the decade?

Tom: Devin Williams. Acquiring him was genius.

Sarah: Worst trade decision in recent history?

Tom: Not trading for Skubal sooner. Or maybe letting some prospects slip through.

Sarah: Final prediction for 2027. We said 85-90 wins last time. Do you bump it up?

Tom: I think 85-90 is realistic. Maybe 87-90. They aren't going to win ninety-five games. The pitching is good, but the offense has holes outside of Soto and Bichette.

Sarah: There you have it. 87 to 90 wins. A solid foundation, but not a dynasty yet. We covered Koosman’s legacy, Bichette’s future, and the roster battles ahead.

Tom: Thanks for listening. Keep your eyes on the Skubal situation and see how Senga handles the bullpen role. It will be an interesting offseason.

Sarah: If you enjoyed this breakdown, please subscribe, rate, and review us on your favorite platform. Share this episode with a fellow Mets fan. Go Mets!